Regulatory Science Students Visit Bay Area Manufacturers

By Laura Sturza

Six students from the USC School of Pharmacy’s regulatory science program received a dose of the real world this summer as they toured two of the San Francisco Bay Area’s major pharmaceutical and medical device companies. The students saw firsthand the operations at Boehringer Ingelheim, one of the world’s leading manufacturers of biopharmaceuticals, and Stryker, one of the world’s leading medical technology companies, on July 22.

Students from the program often tour companies in Southern California, with the goal of gaining additional views of real-world operations. … Read More »

November 20th, 2013|Announcements|

USC researchers to grow organs to unlock secrets of how cancer tumors develop

By Leslie Ridgeway

Using three-dimensional organ creation, Keck Medicine of USC researchers aim to discover clues to metastatic cancer growth by developing a first-ever integrated bioengineered/computational model of metastatic colon cancer.

David B. Agus, MD, director of the USC Center for Applied Molecular Medicine and professor of medicine at the Keck School of Medicine of USC, is the principal investigator of a $2.3 million, four-year “Provocative Questions” grant awarded recently by the National Cancer Institute (NCI), a division of the National Institutes of Health (NIH). The project title is “An Integrative Computational and Bioengineered Tissue Model of Metastasis.” … Read More »

November 13th, 2013|Announcements|

Halloween on the Health Sciences Campus!

Halloween celebrations for kids of all ages took place on the Health Sciences Campus last week, both for spooky fun and to raise awareness for health research initiatives.

… Read More »

November 11th, 2013|Announcements|

Keck Hospital Guild celebrates at fall benefit

The Sports Museum of Los Angeles was the setting for the Keck Hospital of USC Guild’s Oct. 13 fall benefit, “Celebrate an Afternoon Among the Superstars.” Thanks to the generosity of the private museum’s owner and collector Gary Cypress, guests toured more than 30 galleries devoted to sports memorabilia spanning the late 19th century to the present. … Read More »

November 11th, 2013|Announcements|

Drug reduces brain damage, hemorrhaging in rodents afflicted by stroke

By Alison Trinidad

An experimental drug called 3K3A-APC appears to reduce brain damage, eliminate brain hemorrhaging and improve motor skills in older stroke-afflicted mice and stroke-afflicted rats with comorbid conditions such as hypertension, according to a new study from Keck Medicine of USC.

The study, which appears online in the journal Stroke, provides additional evidence that 3K3A-APC may be used as a therapy for stroke in humans, either alone or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator). Clinical trials to test the drug’s efficacy in people experiencing acute ischemic stroke are expected to begin recruiting patients in the United States in 2014. … Read More »

November 11th, 2013|Announcements|